Lobbying Relationship

Client

Adamis Pharmaceuticals Corporation

More records

Lobbying firm

COVINGTON & BURLING LLP

More records

  • Legislation and rulemakings relating to opioid abuse and Naloxone access; H.R. 4007, the HEAL Act; H.R. 4531, the Support for Patients and Communities Reauthorization Act.

Duration: to

General Issues: Health Issues

Spending: about $80,000 (But it's complicated. Here's why.)

Agencies lobbied since 2023: U.S. Senate, House of Representatives

Bills mentioned

H.R.4007: Halting the Epidemic of Addiction and Loss Act of 2023

Sponsor: Kelly Armstrong (R-N.D.)

H.R.4531: Support for Patients and Communities Reauthorization Act

Sponsor: Brett Guthrie (R-Ky.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Gabe Neville Representative Joe Pitts, Chief of Staff, Communications Director, and Special Assistant
Gary Heimberg n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q3 Report
Q2 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page